deferoxamine and tricalcium phosphate

deferoxamine has been researched along with tricalcium phosphate in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
de Vernejoul, MC; Guerin, AP; London, GM; Marchais, SJ; Marty, C; Metivier, F1
Barralet, JE; Drager, J; Gbureck, U; Harvey, EJ; Kumar, A; Ramirez-GarciaLuna, JL1
Wang, ZY; Wei, S; Zhang, RG1

Other Studies

3 other study(ies) available for deferoxamine and tricalcium phosphate

ArticleYear
Arterial calcifications and bone histomorphometry in end-stage renal disease.
    Journal of the American Society of Nephrology : JASN, 2004, Volume: 15, Issue:7

    Topics: Aluminum; Bicarbonates; Bone and Bones; Bone Density; Calcium; Calcium Phosphates; Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; Female; Humans; Kidney Failure, Chronic; Lipid Metabolism; Male; Osteoblasts; Osteoclasts; Parathyroid Hormone; Renal Dialysis

2004
    Tissue engineering. Part A, 2017, Volume: 23, Issue:23-24

    Topics: Animals; Bone Regeneration; Bone Substitutes; Calcium Phosphates; Deferoxamine; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Printing, Three-Dimensional; Rabbits; Ulna

2017
Deferoxamine/magnesium modified β-tricalcium phosphate promotes the bone regeneration in osteoporotic rats.
    Journal of biomaterials applications, 2022, Volume: 37, Issue:5

    Topics: Animals; Bone Regeneration; Calcium Phosphates; Cell Differentiation; Deferoxamine; Magnesium; Osteogenesis; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A

2022